Ontology highlight
ABSTRACT: Background
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease worldwide, and lifestyle modification is the current standard treatment. The aim of the study was to estimate the effect of two different physical activity (PA) programs, a Low Glycemic Index Mediterranean Diet (LGIMD), and their combined effect on the NAFLD score as measured by FibroScan®.Methods
Moderate or severe NAFLD subjects (n = 144) were randomly assigned to six intervention arms during three months. Interventions arms were a control diet, LGIMD, aerobic activity program (PA1), combined activity program (PA2), and LGIMD plus PA1 or LGIMD plus PA2. The data were compared at baseline, at 45 days, and at 90 days. Analysis of variance was performed under the intention-to-treat principle.Results
There was a statistically significant reduction in the NAFLD score after 45 days of treatment in every working arm except for Arm 1 (control diet). After 90 days, the best results were shown by the intervention arms in which LGIMD was associated with PA: LGIMD plus PA1 (-61.56 95% CI -89.61, -33.50) and LGIMD plus PA2 (-38.15 95% CI -64.53, -11.77).Conclusion
All treatments were effective to reduce NAFLD scores, but LGIMD plus PA1 was the most efficient.
SUBMITTER: Franco I
PROVIDER: S-EPMC7823843 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Franco Isabella I Bianco Antonella A Mirizzi Antonella A Campanella Angelo A Bonfiglio Caterina C Sorino Paolo P Notarnicola Maria M Tutino Valeria V Cozzolongo Raffaele R Giannuzzi Vito V Aballay Laura R LR Buongiorno Claudia C Bruno Irene I Osella Alberto R AR
Nutrients 20201228 1
<h4>Background</h4>Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease worldwide, and lifestyle modification is the current standard treatment. The aim of the study was to estimate the effect of two different physical activity (PA) programs, a Low Glycemic Index Mediterranean Diet (LGIMD), and their combined effect on the NAFLD score as measured by FibroScan<sup>®</sup>.<h4>Methods</h4>Moderate or severe NAFLD subjects (<i>n</i> = 144) were randomly assigned to six ...[more]